LSL Pharma Group Inc. (TSXV:LSL)
0.3100
+0.0050 (1.64%)
Nov 4, 2026, 4:00 PM EST
| Market Cap | 39.29M -12.4% |
| Revenue (ttm) | 41.83M +80.0% |
| Net Income | -7.34M |
| EPS | -0.06 |
| Shares Out | 126.73M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 1,501 |
| Open | 0.3050 |
| Previous Close | 0.3050 |
| Day's Range | 0.3050 - 0.3100 |
| 52-Week Range | 0.2600 - 0.5600 |
| Beta | -0.41 |
| Analysts | n/a |
| Price Target | n/a |
| Est. Earnings | Nov 25, 2026 |